2-苄基-1,3-噻唑-4-羧酸 | 36916-44-6

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 唑类
• 中文名称: 2-苄基-1,3-噻唑-4-羧酸
• 中文别名: 2-苄基-1,3-噻唑-4-甲酸；2-(苯基甲基)-噻唑-4-甲酸；2-苄基-噻唑-4-甲酸；2-(苯基甲基)-1,3-噻唑-4-甲酸；2-(苄基)噻唑-4-甲酸
• 英文名称: 2-benzyl-1,3-thiazole-4-carboxylic acid
• 英文别名: 2-benzylthiazole-4-carboxylic acid；2-benzyl-thiazole-4-carboxylic acid；2-Benzyl-thiazol-4-carbonsaeure；2-Benzyl-4-thiazolecarboxylic acid；2-Benzyl-4-carboxythiazol
• CAS: 36916-44-6
• 化学式: C₁₁H₉NO₂S
• mdl: MFCD02102513
• 分子量: 219.264
• InChiKey: OUVVHURAIHESSK-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.8
• 重原子数：
  15
• 可旋转键数：
  3
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.09
• 拓扑面积：
  78.4
• 氢给体数：
  1
• 氢受体数：
  4

安全信息

• 危险品标志：
  Xi
• 海关编码：
  2934100090
• 储存条件：
  储存温度应维持在2-8°C，并需密封保存。

反应信息

• 作为反应物：
  描述：

  2-苄基-1,3-噻唑-4-羧酸 在 N-甲基吗啉 、 氯甲酸乙酯 、 盐酸羟胺 、 potassium hydroxide 作用下， 以 四氢呋喃 、 甲醇 为溶剂， 反应 0.67h， 以5%的产率得到2-benzyl-1,3-thiazole-4-carbohydroxamic acid
  参考文献：
  名称：

  Synthesis and Biological Investigation of Oxazole Hydroxamates as Highly Selective Histone Deacetylase 6 (HDAC6) Inhibitors

  摘要：

  Histone deacetylase 6 (HDAC6) catalyzes the removal of an acetyl group from lysine residues of several nonhistone proteins. Here we report the preparation of thiazole-, oxazole-, and oxadiazole-containing biarylhydroxamic acids by a short synthetic procedure. We identified them as selective HDAC6 inhibitors by investigating the inhibition of B recombinant HDAC enzymes and the protein acetylation in cells by Western blotting (tubulin vs histone acetylation). The most active compounds exhibited nanomolar potency and high selectivity for HDAC6. For example, an oxazole hydroxamate inhibits HDAC6 with an IC50 of 59 nM and has a selectivity index of >200 against HDAC1 and HDAC8. This is the first report showing that the nature of a heterocycle directly connected to a zinc binding group (ZBG) can be used to modulate subtype selectivity and potency for HDAC6 inhibitors to such an extent. We rationalize the high potency and selectivity of the oxazoles by molecular modeling and docking.

  DOI：

  10.1021/acs.jmedchem.5b01493
• 作为产物：
  描述：

  2-苯基硫代乙酰胺 在 氢氧化钾 作用下， 以 乙醇 为溶剂， 生成 2-苄基-1,3-噻唑-4-羧酸
  参考文献：
  名称：

  A catch-and-release strategy for the combinatorial synthesis of 4-acylamino-1,3-thiazoles as potential CDK5 inhibitors

  摘要：

  Two-dimensional libraries of 4-acylamino-1,3-thiazoles 9 were prepared via Curtius rearrangement of 1,3-thiazole-4-carbonyl azides 6, trapping of the intermediate isocyanates with oxime resin, and thermal regeneration of the isocyanates from the washed resin in the presence of nucleophiles. Several compounds proved to be selective inhibitors of CDK5/p25 versus the closely homologous CDK2/cyclin A enzyme, with the best analogue (43) possessing over 100-fold selectivity. (C) 2003 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/s0960-894x(03)00726-1

文献信息

• [EN] PYRIDINONE- AND PYRIDAZINONE-BASED COMPOUNDS AND MEDICAL USES THEREOF<br/>[FR] COMPOSÉS À BASE DE PYRIDINONE ET DE PYRIDAZINONE ET UTILISATIONS MÉDICALES ASSOCIÉES
  申请人：HLA TIMOTHY

  公开号：WO2019173790A1

  公开（公告）日：2019-09-12

  The various examples presented herein are directed to compounds of the formula A-L1-Het1-L2-Cy1 or a pharmaceutical acceptable salt, polymorph, prodrug, solvate or clathrate thereof, wherein: A is cycloalkyl, aryl, arylalkyl or heterocyclyl; Het1 is heterocyclyl containing at least two heteroatoms; Cy1 is a heterocyclyl; L1 is a bond, alkyl, alkenyl or alkynyl linker; L2 is an acyl or alkyl linker; and A and Cy1 are different. The compounds are useful in the treatment of fibrotic diseases, abnormal vascular leak and pathological angiogenesis.

  本文提供的各种示例涉及到以下公式的化合物A-L1-Het1-L2-Cy1或其药用可接受的盐、多型体、前药、溶剂合物或包合物，其中：A为环烷基、芳基、芳基烷基或杂环烷基；Het1为含有至少两个杂原子的杂环烷基；Cy1为杂环烷基；L1为键、烷基、烯基或炔基连接物；L2为酰基或烷基连接物；A和Cy1不同。这些化合物在治疗纤维化疾病、异常血管渗漏和病理性血管生成方面具有用途。
• Pharmacologically active guanidine compounds
  申请人：Smith Kline & French Laboratories Limited

  公开号：US03950333A1

  公开（公告）日：1976-04-13

  The compounds are substituted thioalkyl-, aminoalkyl- and oxyalkyl-guanidines which are inhibitors of histamine activity.

  这些化合物是取代的硫代烷基、氨基烷基和氧烷基胍，它们是组胺活性的抑制剂。
• Pharmacologically active thiourea and urea compounds
  申请人：Smith Kline & French Laboratories Limited

  公开号：US03950353A1

  公开（公告）日：1976-04-13

  The compounds are substituted thioalkyl-, aminoalkyl- and oxyalkyl-thioureas and ureas which are inhibitors of histamine activity.

  这些化合物是取代的硫代烷基、氨基烷基和氧烷基硫脲和脲，它们是组胺活性的抑制剂。
• [EN] ACYL PIPERAZINE DERIVATIVES AS TTX-S BLOCKERS<br/>[FR] DÉRIVÉS D'ACYLPIPÉRAZINE À TITRE DE BLOQUEURS DE TTX-S
  申请人：RAQUALIA PHARMA INC

  公开号：WO2012020567A1

  公开（公告）日：2012-02-16

  The present invention relates to acyl piperazine derivatives which have blocking activities of voltage gated sodium channels as the TTX-S channels, and which are useful in the treatment or prevention of disorders and diseases in which voltage gated sodium channels are involved. The invention also relates to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which voltage gated sodium channels are involved.

  本发明涉及酰基哌嗪衍生物，具有阻断电压门控钠通道（如TTX-S通道）活性的特性，可用于治疗或预防涉及电压门控钠通道的疾病和疾病。该发明还涉及包含这些化合物的药物组合物以及在预防或治疗涉及电压门控钠通道的疾病中使用这些化合物和组合物。
• Beiträge zum Studium einiger Heterocyclen, 49. Mitt. Darstellung und Konfigurationsbestimmung der Oxime von 2-Benzyl-4-acetyl-5-Y-thiazolen und 2-Benzoyl-4-methoxycarbonyl-5-Y-thiazolen
  作者：Ioan Simiti、Gheorghe Hintz

  DOI：10.1002/ardp.19793120305

  日期：——

  Es wird die Darstellung von 2‐Benzyl‐4‐acetyl‐5‐Y‐thiazolen und 2‐Benzoyl‐4‐methylcarbonyl‐5‐Y‐thiazolen untersucht. Bei Behandlung mit Hydroxylamin wird im Falle der ersten Verbindungen ein einziges Oxim erhalten, dessen Konfiguration ein Anti‐thiazol ist. Im Falle der zweiten Verbindungsgruppe werden zwei isomere Oxime in verschiedenen Mengenverhältnissen erhalten. Die Struktur der Verbindungen wurde

  Es wird die Darstellung von 2-Benzyl-4-acetyl-5-Y-thiazolen 和 2-Benzoyl-4-methylcarbonyl-5-Y-thiazolen untersucht。Bei Behandlung mit Hydroxylamin wird im Falle der ersten Verbindungen ein einziges Oxim erhalten, dessen Konfiguration ein Anti-thiazolist。Im Falle der zweiten Verbindungsgruppe werden zwei isomere 肟 in verschiedenen Mengenverhältnissen erhalten。Die Struktur der Verbindungen wurde mit Hilfe